Significant fatigue or energy crashes that do not resolve by mid-week
GLP-1 Medications Fight Weight With Biology GLP-1s are different from older classes of prescription weight loss medications (like phentermine) because they work on key underlying metabolic pathways to support sustained weight loss
The impact of GLP-1 and incretin-based therapies on counterregulatory responses to hypoglycemia in diabetes mellitus
Per HumeCare's Medications Safety Information, the most commonly reported side effects are typically mild and tend to resolve after the first several weeks of treatment: nausea, vomiting, diarrhea, constipation, abdominal pain, upset stomach, abdominal distension, reflux, headache, fatigue, and dizziness
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
According to research published in the National Institutes of Health, even with a special absorption enhancer called SNAC (sodium N-[8-[2-hydroxylbenzoyl] amino] caprylate), less than 1% of the medication in each pill makes it into your bloodstream